Fig. 3: Expression of Herpes Virus Entry Mediator and Programmed Death-Ligand. | Nature Communications

Fig. 3: Expression of Herpes Virus Entry Mediator and Programmed Death-Ligand.

From: Tifcemalimab as monotherapy or in combination with toripalimab in patients with relapsed/refractory lymphoma: a Phase I trial

Fig. 3: Expression of Herpes Virus Entry Mediator and Programmed Death-Ligand.

Figure (A) shows the membrane staining score of HEVM and tumor response. Figure (B) shows the membrane staining score of PD-L1 and tumor response. CR = complete response, PR = partial response, SD = stable disease, PD = progressive disease. Source data are provided as a Source Data file. N means the number of patients.

Back to article page